AJNN
Academic Journal of Neuropsychiatry and Psychology

Academic Journal of Neuropsychiatry and Psychology (formerly known as the Academic Journal of Neurology and Neurosurgery, e-ISSN:3023-6517), deals with neurology, neurosurgery, psychiatry and clinical psychology accepts articles on these topics. Academic Journal of Neuropsychiatry and Psychology publishes original research articles, review articles, case reports, editorial commentaries, letters to the editor, educational articles, and conference/meeting announcements.

Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Online Manuscript System

Index
Letter to the Editor
Intranasal bromocriptine in Parkinson’s disease: a nasocerebral leap in dopaminergic therapy
Abstract
We write to bring to the foremost awareness and consideration, a novel modality of Parkinson's disease treatment. This novel, non-invasive brain-targeted therapy, offers a promising milieu for the clinical management of Parkinson's disease.

Keywords : Bromocriptine mesylate, Parkinson's disease, neurobiology

Download Article


1. Dong-Chen X, Yong C, Yang X, Chen-Yu S, Li-Hua P. Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions.Signal Transduct Target Ther. 2023;8(1):73. doi:10.1038/s41392-023-01353-3
2. Ivan IF, Irincu VL, Diaconu ?, Falup-Pecurariu O, Ciopleia? B, Falup-Pecurariu C. Gastro-intestinal dysfunctions in Parkinson’s disease (Review). Exp Ther Med. 2021;22(4):1083. doi:10.3892/etm.2021.10517
3. Darshan KA, Desai AR, Shalavadi M, Nainegali BS, Vijapur LS. Development and characterization of bromocriptine mesylate loaded nanostructured lipid carriers for enhanced nose-to-brain delivery.Precision Nanomedicine. 2025;8(4):1586-1603. doi:10.33218/?001c.144483
4. Lababidi JM, Azzazy HME. Revamping Parkinson’s disease therapy using PLGA-based drug delivery systems.NPJ Parkinson’s Dis. 2025; 11(1):248. doi:10.1038/s41531-025-01081-1
Article available in :
Volume 2, Issue 4, 2025
Page : 91-92
https://doi.org/10.51271/AJNN-0041
Article Information
Received : 24 Eki 2025
Accepted : 29 Ara 2025
Published : 31 Ara 2025
Corresponding Author :

Patrick Ashinze: Faculty of Clinical Sciences, University of Ilorin Teaching Hospital, Ilorin, Nigeria

[email protected]
Citation : Ashinze P, Balogun DB, Ogunruku DO, et al. Intranasal bromocriptine in Parkinson’s disease: a nasocerebral leap in dopaminergic therapy. Acad J Neurol Neurosurg. 2025;2(4):91-92.

Read: 112
Download : 163
Cited: 0
_Footer